VivoSim Net Debt vs Net Receivables Analysis

VIVS Stock

1.86 0.11 6.29%

VivoSim Labs, financial indicator trend analysis is much more than just breaking down VivoSim Labs, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VivoSim Labs, is a good investment. Please check the relationship between VivoSim Labs, Net Debt and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VivoSim Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy VivoSim Stock please use our How to Invest in VivoSim Labs, guide.

Net Debt vs Net Receivables

Net Debt vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VivoSim Labs, Net Debt account and Net Receivables. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between VivoSim Labs,'s Net Debt and Net Receivables is -0.55. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Net Receivables in the same time period over historical financial statements of VivoSim Labs,, assuming nothing else is changed. The correlation between historical values of VivoSim Labs,'s Net Debt and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of VivoSim Labs, are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Net Debt i.e., VivoSim Labs,'s Net Debt and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.55

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Net Receivables

Most indicators from VivoSim Labs,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VivoSim Labs, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VivoSim Labs,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy VivoSim Stock please use our How to Invest in VivoSim Labs, guide.At this time, VivoSim Labs,'s Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 56.08 in 2025, whereas Tax Provision is likely to drop 1,600 in 2025.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	18.1M	15.2M	12.8M	18.0M
Depreciation And Amortization	293K	280K	266K	424.6K

Other Operating Expenses Depreciation And Amortization

VivoSim Labs, fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Current Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Short Term Debt	Current Deferred Revenue	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.16	0.95	-0.98	0.02	0.23	0.98	0.98	-0.25	0.78	0.18	-0.15	0.98	0.71	0.4	-0.46	0.58	0.49	-0.2	0.54	0.12	0.23	0.19	0.45	0.5	-0.38
Total Current Liabilities	-0.16		-0.41	0.13	0.5	-0.07	-0.14	-0.14	-0.37	-0.26	-0.57	1.0	-0.13	0.25	-0.45	0.71	-0.2	-0.27	-0.31	0.04	-0.29	0.29	-0.49	-0.43	0.23	-0.27
Total Stockholder Equity	0.95	-0.41		-0.95	-0.06	0.14	0.96	0.96	-0.22	0.75	0.3	-0.41	0.96	0.6	0.48	-0.6	0.54	0.48	-0.18	0.51	0.16	0.16	0.3	0.49	0.44	-0.34
Net Debt	-0.98	0.13	-0.95		-0.13	-0.12	-1.0	-1.0	0.39	-0.71	-0.1	0.13	-1.0	-0.74	-0.35	0.4	-0.48	-0.38	0.32	-0.55	-0.02	-0.26	-0.12	-0.36	-0.59	0.5
Retained Earnings	0.02	0.5	-0.06	-0.13		-0.4	0.12	0.11	-0.77	-0.52	-0.95	0.47	0.11	0.37	-0.66	0.77	-0.28	-0.43	-0.7	0.16	-0.56	0.34	-0.84	-0.65	0.67	-0.67
Accounts Payable	0.23	-0.07	0.14	-0.12	-0.4		0.12	0.11	0.65	0.4	0.32	-0.07	0.12	0.01	-0.01	-0.36	0.31	0.33	0.4	-0.05	0.06	-0.22	0.19	0.35	-0.37	0.19
Cash	0.98	-0.14	0.96	-1.0	0.12	0.12		1.0	-0.38	0.72	0.12	-0.13	1.0	0.73	0.37	-0.41	0.49	0.4	-0.31	0.54	0.05	0.25	0.14	0.38	0.58	-0.48
Cash And Short Term Investments	0.98	-0.14	0.96	-1.0	0.11	0.11	1.0		-0.38	0.72	0.12	-0.13	1.0	0.73	0.37	-0.41	0.5	0.4	-0.3	0.54	0.05	0.25	0.14	0.38	0.58	-0.47
Common Stock Shares Outstanding	-0.25	-0.37	-0.22	0.39	-0.77	0.65	-0.38	-0.38		0.17	0.6	-0.36	-0.38	-0.54	0.19	-0.47	0.12	0.29	0.85	-0.36	0.34	-0.46	0.48	0.41	-0.77	0.69
Other Current Assets	0.78	-0.26	0.75	-0.71	-0.52	0.4	0.72	0.72	0.17		0.65	-0.24	0.73	0.47	0.59	-0.78	0.51	0.52	0.17	0.43	0.29	0.04	0.53	0.58	0.05	0.01
Other Stockholder Equity	0.18	-0.57	0.3	-0.1	-0.95	0.32	0.12	0.12	0.6	0.65		-0.53	0.13	-0.19	0.78	-0.87	0.36	0.51	0.57	-0.02	0.58	-0.26	0.91	0.73	-0.52	0.54
Total Liab	-0.15	1.0	-0.41	0.13	0.47	-0.07	-0.13	-0.13	-0.36	-0.24	-0.53		-0.13	0.26	-0.41	0.69	-0.14	-0.21	-0.29	0.04	-0.22	0.29	-0.45	-0.39	0.2	-0.21
Total Current Assets	0.98	-0.13	0.96	-1.0	0.11	0.12	1.0	1.0	-0.38	0.73	0.13	-0.13		0.74	0.38	-0.42	0.5	0.41	-0.31	0.56	0.06	0.27	0.15	0.38	0.57	-0.47
Common Stock	0.71	0.25	0.6	-0.74	0.37	0.01	0.73	0.73	-0.54	0.47	-0.19	0.26	0.74		0.09	0.0	0.39	0.23	-0.6	0.81	-0.08	0.7	-0.1	0.09	0.57	-0.6
Short Long Term Debt Total	0.4	-0.45	0.48	-0.35	-0.66	-0.01	0.37	0.37	0.19	0.59	0.78	-0.41	0.38	0.09		-0.64	0.5	0.54	0.22	0.28	0.58	0.14	0.92	0.82	-0.04	0.19
Other Current Liab	-0.46	0.71	-0.6	0.4	0.77	-0.36	-0.41	-0.41	-0.47	-0.78	-0.87	0.69	-0.42	0.0	-0.64		-0.39	-0.47	-0.4	-0.04	-0.44	0.32	-0.7	-0.67	0.32	-0.35
Property Plant And Equipment Net	0.58	-0.2	0.54	-0.48	-0.28	0.31	0.49	0.5	0.12	0.51	0.36	-0.14	0.5	0.39	0.5	-0.39		0.95	0.03	0.43	0.76	0.32	0.46	0.66	-0.14	0.29
Non Current Assets Total	0.49	-0.27	0.48	-0.38	-0.43	0.33	0.4	0.4	0.29	0.52	0.51	-0.21	0.41	0.23	0.54	-0.47	0.95		0.3	0.29	0.83	0.18	0.57	0.7	-0.28	0.44
Non Currrent Assets Other	-0.2	-0.31	-0.18	0.32	-0.7	0.4	-0.31	-0.3	0.85	0.17	0.57	-0.29	-0.31	-0.6	0.22	-0.4	0.03	0.3		-0.47	0.33	-0.54	0.43	0.32	-0.59	0.65
Net Receivables	0.54	0.04	0.51	-0.55	0.16	-0.05	0.54	0.54	-0.36	0.43	-0.02	0.04	0.56	0.81	0.28	-0.04	0.43	0.29	-0.47		0.02	0.84	0.12	0.18	0.43	-0.45
Non Current Liabilities Total	0.12	-0.29	0.16	-0.02	-0.56	0.06	0.05	0.05	0.34	0.29	0.58	-0.22	0.06	-0.08	0.58	-0.44	0.76	0.83	0.33	0.02		-0.02	0.62	0.58	-0.46	0.75
Inventory	0.23	0.29	0.16	-0.26	0.34	-0.22	0.25	0.25	-0.46	0.04	-0.26	0.29	0.27	0.7	0.14	0.32	0.32	0.18	-0.54	0.84	-0.02		0.01	0.07	0.36	-0.47
Short Term Debt	0.19	-0.49	0.3	-0.12	-0.84	0.19	0.14	0.14	0.48	0.53	0.91	-0.45	0.15	-0.1	0.92	-0.7	0.46	0.57	0.43	0.12	0.62	0.01		0.86	-0.4	0.4
Current Deferred Revenue	0.45	-0.43	0.49	-0.36	-0.65	0.35	0.38	0.38	0.41	0.58	0.73	-0.39	0.38	0.09	0.82	-0.67	0.66	0.7	0.32	0.18	0.58	0.07	0.86		-0.25	0.24
Net Invested Capital	0.5	0.23	0.44	-0.59	0.67	-0.37	0.58	0.58	-0.77	0.05	-0.52	0.2	0.57	0.57	-0.04	0.32	-0.14	-0.28	-0.59	0.43	-0.46	0.36	-0.4	-0.25		-0.83
Property Plant And Equipment Gross	-0.38	-0.27	-0.34	0.5	-0.67	0.19	-0.48	-0.47	0.69	0.01	0.54	-0.21	-0.47	-0.6	0.19	-0.35	0.29	0.44	0.65	-0.45	0.75	-0.47	0.4	0.24	-0.83

Click cells to compare fundamentals

VivoSim Labs, Account Relationship Matchups

VivoSim Labs, fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	39.9M	33.3M	20.3M	6.3M	14.7M	28.0M
Total Current Liabilities	1.8M	721K	1.4M	3.7M	1.9M	3.5M
Total Stockholder Equity	39.2M	30.2M	15.3M	3.6M	10.5M	10.0M
Net Debt	(37.4M)	(26.5M)	(13.5M)	(1.5M)	(10.4M)	(10.9M)
Retained Earnings	(296.3M)	(307.7M)	(325.0M)	(339.7M)	(342.2M)	(359.3M)
Accounts Payable	281K	415K	331K	627K	1.6M	1.7M
Cash	37.4M	28.7M	15.3M	2.9M	11.3M	10.7M
Cash And Short Term Investments	37.4M	28.7M	16.0M	2.9M	11.3M	10.7M
Common Stock Shares Outstanding	575.2K	725.3K	726.1K	762.1K	1.5M	1.5M
Liabilities And Stockholders Equity	39.9M	33.3M	20.3M	6.3M	14.7M	28.0M
Other Current Assets	1.0M	858K	889K	705K	789K	940.1K
Other Stockholder Equity	335.5M	337.9M	340.3M	343.3M	352.6M	269.7M
Total Liab	721K	3.1M	5.0M	2.7M	4.2M	3.9M
Total Current Assets	38.4M	29.5M	17.0M	3.9M	12.1M	11.5M
Common Stock	124K	7K	9K	10K	2K	1.9K
Other Current Liab	440K	489K	2.8M	727K	1.6M	2.9M
Non Current Assets Total	1.5M	3.8M	3.3M	2.4M	2.5M	2.6M
Non Currrent Assets Other	1.1M	948K	658K	445K	1.2M	1.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for VivoSim Stock Analysis

When running VivoSim Labs,'s price analysis, check to measure VivoSim Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VivoSim Labs, is operating at the current time. Most of VivoSim Labs,'s value examination focuses on studying past and present price action to predict the probability of VivoSim Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VivoSim Labs,'s price. Additionally, you may evaluate how the addition of VivoSim Labs, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC